March 17, 2020
Atropos is pleased to announce the recruitment of two individuals, Ethan Than MBA and Harsha Agarwal PhD, to our Business Development and Laboratory efforts. >>
Atropos is pleased to announce the recent submission of our non-provisional patent by WSGR describing the FATES platform for identification of senomodulators.
February 26, 2020
Atropos welcomes William D. Tap to the Board of Directors. Bill is the Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center. He has experience in translational medicine and drug development. >>